[1]
|
P. Coy and G. M. Kennelly, “The Role of Curative Radiotherapy in the Treatment of Lung Cancer,” Cancer, Vol. 45, 1980, pp. 698-702.
doi:10.1002/1097-0142(19800215)45:4<698::AID-CNCR2820450414>3.0.CO;2-8
|
[2]
|
P. H. Graham, V. J. Gebski and A. O. Langlands, “Radical Radiotherapy for Early Nonsmall Cell Lung Cancer,” International Journal of Radiation Oncology ? Biology ? Physics, Vol. 31, 1995, pp. 261-266.
doi:10.1016/0360-3016(94)E0137-9
|
[3]
|
D. E. Dosoretz, M. J. Katin, P. H. Blitzer, et al., “Medically Inoperable Lung Carcinoma: The Role of Radiation Therapy,” Seminars in Radiation Oncology, Vol. 6, No. 2, 1996, pp. 98-104.
doi:10.1016/S1053-4296(96)80006-3
|
[4]
|
J. Noble, P. M. Ellis, J. A. Mackay and W. K. Evans, “Second-Line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Cell Lung Cancer: A Systematic Review and Practice Guideline,” Journal of Thoracic Oncology, Vol. 1, No. 9, 2006, pp. 1042-1058.
doi:10.1097/01243894-200611000-00021
|
[5]
|
K. L. Wu, G. L. Jiang, H. Qian, et al., “Three-Dimensional Conformal Radiotherapy for Locoregionally Recurrent Lung Carcinoma after External Beam Irradiation: A Prospective Phase I-II Clinical Trial,” International Journal of Radiation Oncology ? Biology ? Physics, Vol. 57, No. 5, 2003, pp. 1345-1350.
doi:10.1016/S0360-3016(03)00768-5
|
[6]
|
T. Tada, H. Fukuda, K. Matsui, et al., “Non-Small-Cell Lung Cancer: Reirradiation for Loco-Regional Relapse Previously Treated with Radiation Therapy,” International Journal of Clinical Oncology, Vol. 10, No. 4, 2005, pp. 247-250. doi:10.1007/s10147-005-0501-1
|
[7]
|
Y. Okamoto, M. Murakami, E. Yoden, et al., “Reirradiation for Locally Recurrent Lung Cancer Previously Treated with Radiation Therapy,” International Journal of Radiation Oncology ? Biology ? Physics, Vol. 52, No. 2, 2002, pp. 390-396.
doi:10.1016/S0360-3016(01)02644-X
|
[8]
|
N. Green and R. W. Melbye, “Lung Cancer: Retreatment of Local Recurrence after Definitive Irradiation,” Cancer, Vol. 49, No. 5, 1982, pp. 865-868.
doi:10.1002/1097-0142(19820301)49:5<865::AID-CNCR2820490507>3.0.CO;2-H
|
[9]
|
J. F. Montebello, B. S. Aron, A. K. Manatunga, J. L. Horvath and F. W. Peyton, “The Reirradiation of Recurrent Bronchogenic Carcinoma with External Beam Irradiation,” American Journal of Clinical Oncology, Vol. 16, No. 6, 1993, pp. 482-488.
doi:10.1097/00000421-199312000-00004
|
[10]
|
L. Leksell, “The Stereotaxic Method and Radiosurgery of the Brain,” Acta Chirurgica Scandinavica, Vol. 102, No. 4, 1951, pp. 316-319.
|
[11]
|
J. C. Flickinger, D. Kondziolka and L. D. Lunsford, “Clinical Applications of Stereotactic Radiosurgery,” Cancer Treatment and Research, Vol. 93, 1998, pp. 283-297.
|
[12]
|
D. A. Larson, P. H. Gutin, S. A. Leibel, T. L. Phillips, P. K. Sneed and W. M. Wara, “Stereotaxic Irradiation of Brain Tumors,” Cancer, Vol. 65, No. S3, 1990, pp. 792-799.
doi:10.1002/1097-0142(19900201)65:3+<792::AID-CNCR2820651327>3.0.CO;2-P
|
[13]
|
J. S. Loeffler, D. C. Shrieve, P. Y. Wen, et al., “Radiosurgery for Intracranial Malignancies,” Seminars in Radiation Oncology, Vol. 5, No. 3, 1995, pp. 225-234.
doi:10.1016/S1053-4296(05)80021-9
|
[14]
|
D. Kondziolka, A. Patel, L. D. Lunsford, A. Kassam and J. C. Flickinger, “Stereotactic Radiosurgery Plus Whole Brain Radiotherapy Versus Radiotherapy Alone for Patients with Multiple Brain Metastases,” International Journal of Radiation Oncology ? Biology ? Physics, Vol. 45, No. 2, 1999, pp. 427-434.
doi:10.1016/S0360-3016(99)00198-4
|
[15]
|
D. W. Andrews, C. B. Scott, P. W. Sperduto, et al., “Whole Brain Radiation Therapy with or without Stereotactic Radiosurgery Boost for Patients with One to Three Brain Metastases: Phase III Results of the RTOG 9508 Randomised Tria,” Lancet, Vol. 363, 2004, pp. 1665- 1672. doi:10.1016/S0140-6736(04)16250-8
|
[16]
|
K. K. Ang, L. J. Peters, R. S. Weber, et al., “Postoperative Radiotherapy for Cutaneous Melanoma of the Head and Neck Region,” International Journal of Radiation Oncology ? Biology ? Physics, Vol. 30, No. 4, 1994, pp. 795-798.
|
[17]
|
M. D. Bonnen, M. T. Ballo, J. N. Myers, et al., “Elective Radiotherapy Provides Regional Control for Patients with Cutaneous Melanoma of the Head and Neck,” Cancer, Vol. 100, No. 2, 2004, pp. 383-389.
doi:10.1002/cncr.11921
|
[18]
|
S. K. Seung, P. K. Sneed, M. W. McDermott, et al., “Gamma Knife Radiosurgery for Malignant Melanoma Brain Metastases,” Cancer Journal from Scientific American, Vol. 4, No. 2, 1998, pp. 103-109.
|
[19]
|
J. M. Balter and M. L. Kessler, “Imaging and Alignment for Image-Guided Radiation Therapy,” Journal of Clinical Oncology, Vol. 25, No. 8, 2007, pp. 931-937.
doi:10.1200/JCO.2006.09.7998
|
[20]
|
R. D. Timmerman, B. D. Kavanagh, L. C. Cho, L. Papiez and L. Xing, “Stereotactic Body Radiation Therapy in Multiple Organ Sites,” Journal of Clinical Oncology, Vol. 25, 2007, pp. 947-952.
doi:10.1200/JCO.2006.09.7469
|
[21]
|
L. Potters, M. Steinberg, C. Rose, et al., “American Society for Therapeutic Radiology and Oncology and American College of Radiology Practice Guideline for the Performance of Stereotactic Body Radiation Therapy,” International Journal of Radiation Oncology ? Biology ? Physics, Vol. 60, No. 4, 2004, pp. 1026-1032.
doi:10.1016/j.ijrobp.2004.07.701
|
[22]
|
L. Papiez, R. Timmerman, C. DesRosiers and M. Randall, “Extracranial Stereotactic Radioablation: Physical Principles,” Acta Oncologica, Vol. 42, No. 8, 2003, pp. 882-894. doi:10.1080/02841860310013490
|
[23]
|
H. Hof, K. K. Herfarth, M. Munter, et al., “Stereotactic Single-Dose Radiotherapy of Stage I Non-Small-Cell Lung Cancer (NSCLC),” International Journal of Radiation Oncology ? Biology ? Physics, Vol. 56, No. 2, 2003, pp. 335-341. doi:10.1016/S0360-3016(02)04504-2
|
[24]
|
R. D. Timmerman, L. Papiez, R. McGarry, et al., “Extracranial Stereotactic Radioablation: Results of a Phase I Study in Stage I Non-Small Cell Lung Cancer,” International Journal of Radiation Oncology ? Biology ? Physics, Vol. 124, No. 5, 2003, pp. S280-S281.
doi:10.1016/S0360-3016(03)01131-3
|
[25]
|
Y. Nagata, Y. Negoro, T. Aoki, et al., “Clinical Outcomes of 3D Conformal Hypofractionated Single High-Dose Radiotherapy for One or Two Lung Tumors Using a Stereotactic Body Frame,” International Journal of Radiation Oncology ? Biology ? Physics, Vol. 52, No. 4, 2002, pp. 1041-1046.
doi:10.1016/S0360-3016(01)02731-6
|
[26]
|
M. Uematsu, A. Shioda, K. Tahara, et al., “Focal, High Dose, and Fractionated Modified Stereotactic Radiation Therapy for Lung Carcinoma Patients: A Preliminary Experience,” Cancer, Vol. 82, No. 6, 1998, pp. 1062- 1070.
doi:10.1002/(SICI)1097-0142(19980315)82:6<1062::AID-CNCR8>3.0.CO;2-G
|
[27]
|
H. Onishi, T. Araki, H. Shirato, et al., “Stereotactic Hypofractionated High-Dose Irradiation for Stage I Nonsmall Cell Lung Carcinoma: Clinical Outcomes in 245 Subjects in a Japanese Multiinstitutional Study,” Cancer, Vol. 101, No. 7, 2004, pp. 1623-1631.
doi:10.1002/cncr.20539
|
[28]
|
Q. T. Le, B. W. Loo, A. Ho, et al., “Results of a Phase I Dose-Escalation Study Using Single-Fraction Stereotactic Radiotherapy for Lung Tumors,” Journal of Thoracic Oncology, Vol. 1, No. 8, 2006, pp. 802-809.
doi:10.1097/01243894-200610000-00008
|
[29]
|
P. Kelly, P. A. Balter, N. Rebueno, et al., “Stereotactic Body Radiation Therapy for Patients with Lung Cancer Previously Treated with Thoracic Radiation,” International Journal of Radiation Oncology ? Biology ? Physics, Vol. 78, No. 5, pp. 1387-1393.
doi:10.1016/j.ijrobp.2009.09.070
|